MedTrace Logo

IMPROVEMENT in ERADICATION of H-PYLORI INFECTION

NCT05701683 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 195

Last updated 2023-02-10

No results posted yet for this study

Summary

Efficacy in terms of H pylori eradication of clarithromycin based sequential therapy with lactobacillus is better than sequential based therapy alone.

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Lactobacillus Reuteri Probiotic

Experimental group receiving Lactobacillus Reuteri Probiotic with sequential therapy

Sponsors & Collaborators

  • Liaquat National Hospital & Medical College

    lead OTHER

Principal Investigators

  • Mehreen Akmal, MBBS · Liaquat National Hospital & Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-15
Primary Completion
2021-11-20
Completion
2022-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05701683 on ClinicalTrials.gov